slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 90,061-90,090
Pages 3,685
Rows per page 30
Component
90,061-90,090 of 110,539
03
Includes financial strength ratings from AM Best and S&P Global.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Setup1 hit
06
International General Insurance | Results Presentation Deck | 20 slidesInternational General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Why1 hit
10
The slide highlights diversification across multiple dimensions including geography and lines of business.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
11
The chart uses a stacked bar for GWP (Reinsurance, Long-Tail, Short-Tail) and a line chart for the Combined Ratio.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
12
The chart uses a dual-axis approach: stacked bars for loss amounts ($Billions) and a line graph for the Combined Ratio (%).International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
14
The slide highlights the company's approach to IBNR reserves and balance sheet management.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
04
Invitae | Results Presentation Deck | 28 slidesInvitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Attention1 hit
17
Invitae | Results Presentation Deck | 28 slidesInvitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Takeaways1 hit
04
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
05
The slide uses a causal-chain/before-after-bridge hybrid structure to link specific problems to specific solutions.jetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
06
jetBlue | Results Presentation Deck | 19 slidesjetBlue | Results Presentation Deck | 19 slides · jetBlue
Conference presentation Investor relations Beat · WhyLoop · Cost Of Inaction1 hit
03
The slide uses a split-layout with company identity on the left and a list of achievements on the right.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Attention1 hit
04
TPD = Targeted Protein Degradation. The slide uses a four-column layout to structure the company's value proposition.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
08
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
10
The slide uses a biological pathway diagram to illustrate the mechanism of action and a callout box for the therapeutic thesis.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
20
The slide displays 12 individual bar charts (4 for AD, 8 for HS) representing gene expression changes.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
23
Includes before/after photography, clinical efficacy table, and biomarker reduction charts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment1 hit
24
The slide uses a comparison table to highlight efficacy metrics (EASI, Pruritus NRS) across different time points and benchmarks.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment1 hit
27
The charts demonstrate a shift from higher severity scores (orange/red) to lower severity scores (blue/black) over time.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
30
The slide uses a comparison table to highlight superior efficacy metrics for the drug candidate.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
32
Data presented as mean change from baseline with 90% CI. Includes table of mean values for delta QTc and absolute QTc.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
35
The slide uses a complex biological pathway diagram to illustrate the mechanism of action and the problem of redundant signaling pathways.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
39
The slide presents longitudinal pharmacodynamic (PD) data for three targets across four dose levels, comparing clinical results to preclinical expectations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
42
Includes a table of prevalence/incidence data and a biological pathway diagram.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
45
Clinical trial safety data presentation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
47
Includes a line chart showing % change over time and a summary table of patient-level degradation data.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
48
Includes bar charts for SAA/CRP, a longitudinal line chart for SOCS3, and a scatter plot showing correlation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
52
The slide uses a biological pathway diagram to illustrate the mechanism of action and Western blot data to validate the claim.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
53
Includes a table comparing clinical stage and potency metrics (IC50, DC50) across multiple competitors.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
54
Data presented as tumor volume growth curves and Kaplan-Meier survival plots.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit